Genetic deletion of MKL1 in endothelial cells or pharmaceutical inhibition of MKL1 or STAT3 or TWIST1 is sufficient to alleviate liver fibrosis in mice. This evidence concerns the gene STAT3 and Hepatic fibrosis.